Wellington Management Group LLP Boosts Stock Position in Haleon plc (NYSE:HLN)

Wellington Management Group LLP raised its stake in Haleon plc (NYSE:HLN) by 49.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 9,152,490 shares of the company’s stock after acquiring an additional 3,046,841 shares during the period. Wellington Management Group LLP’s holdings in Haleon were worth $96,833,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the stock. FMR LLC lifted its holdings in shares of Haleon by 5.8% during the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock worth $1,110,035,000 after purchasing an additional 5,768,117 shares during the period. Sculptor Capital LP lifted its stake in shares of Haleon by 67.8% in the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after acquiring an additional 3,592,000 shares during the period. Clearbridge Investments LLC boosted its holdings in shares of Haleon by 8.6% in the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock valued at $344,888,000 after acquiring an additional 3,307,009 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Haleon by 95.5% during the second quarter. The Manufacturers Life Insurance Company now owns 1,954,304 shares of the company’s stock worth $16,143,000 after acquiring an additional 954,622 shares during the period. Finally, Natixis Advisors LLC raised its holdings in Haleon by 142.5% during the third quarter. Natixis Advisors LLC now owns 1,473,767 shares of the company’s stock worth $15,593,000 after purchasing an additional 866,070 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Down 0.4 %

Shares of NYSE HLN opened at $9.64 on Tuesday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The firm has a 50-day moving average price of $9.81 and a 200 day moving average price of $9.49. Haleon plc has a 52 week low of $7.89 and a 52 week high of $10.80. The stock has a market capitalization of $43.61 billion, a price-to-earnings ratio of 28.34, a price-to-earnings-growth ratio of 2.92 and a beta of 0.28.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on HLN shares. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Morgan Stanley lifted their price target on Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Haleon presently has an average rating of “Buy” and an average price target of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.